| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.04. | Bloom Burton & Co. Inc.: Cheelcare to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference | 263 | Newsfile | Markham, Ontario--(Newsfile Corp. - April 14, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, announced today... ► Artikel lesen | |
| 09.04. | Cheelcare Inc: Cheelcare delivers Curio robotic/rehab power wheelchair | 1 | Stockwatch | ||
| 09.04. | Cheelcare Inc.: Cheelcare Delivers First Curio Robotic Complex-Rehab Power Wheelchair to Paying Customers and Achieves Record Companion Sales | 176 | Newsfile | Markham, Ontario--(Newsfile Corp. - April 9, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced... ► Artikel lesen | |
| 25.03. | Cheelcare Inc: Cheelcare loses $509,824 in fiscal Q3 | 1 | Stockwatch | ||
| CHEELCARE Aktie jetzt für 0€ handeln | |||||
| 25.03. | Cheelcare GAAP EPS of -C$0.02, revenue of C$0.55M | 2 | Seeking Alpha | ||
| 25.03. | Cheelcare Inc.: Cheelcare Announces Third Quarter 2026 Financial Results | 249 | Newsfile | Markham, Ontario--(Newsfile Corp. - March 25, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced... ► Artikel lesen | |
| 19.02. | Cheelcare Inc: Cheelcare shares for loan | 1 | Stockwatch | ||
| 19.02. | Cheelcare Inc: Cheelcare closes $1-million note financing | 2 | Stockwatch | ||
| 18.02. | Cheelcare Inc.: Cheelcare Closes $1.0 Million Unsecured Note Financing | 298 | Newsfile | Markham, Ontario--(Newsfile Corp. - February 18, 2026) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that it... ► Artikel lesen | |
| 09.02. | Cheelcare Inc: Cheelcare arranges $1-million note offering | 1 | Stockwatch | ||
| 09.02. | Cheelcare Inc.: Cheelcare Announces $1.0 Million Unsecured Note Financing | 189 | Newsfile | Markham, Ontario--(Newsfile Corp. - February 9, 2026) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that it has... ► Artikel lesen | |
| 27.01. | Cheelcare Inc: Cheelcare receives Medicare/Medicaid OK for Companion | 1 | Stockwatch | ||
| 26.01. | Cheelcare Inc.: Cheelcare Announces Medicare and Medicaid Services Reimbursement Approval for Companion Power Assist Device, Expanding U.S. Market Access | 236 | Newsfile | Investment Highlights:U.S. Medicare and Medicaid reimbursement eligibility achieved:The Company has received Pricing, Data Analysis, and Coding ("PDAC") verification, enabling U.S. Medicare and... ► Artikel lesen | |
| 31.12.25 | Cheelcare Inc. GAAP EPS of -$0.03, revenue of $0.39M | 2 | Seeking Alpha | ||
| 30.12.25 | Cheelcare Inc.: Cheelcare Announces Second Quarter Fiscal 2026 Financial Results | 457 | Newsfile | Markham, Ontario--(Newsfile Corp. - December 30, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced its financial... ► Artikel lesen | |
| 08.12.25 | Cheelcare Inc: Cheelcare reaches 2,000 Companion units sold | 2 | Stockwatch | ||
| 08.12.25 | Cheelcare Inc.: Cheelcare Has a Record Month of Sales and Celebrates Milestone of 2,000 Companions Sold | 276 | Newsfile | Markham, Ontario--(Newsfile Corp. - December 8, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, is proud to announce that the Company has reached a major commercial... ► Artikel lesen | |
| 02.12.25 | Cheelcare Inc.: Cheelcare to Represent Canadian Health Innovation at Health Tech Forward 2025 in Barcelona | 306 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, was selected to participate in a Canadian trade mission to Barcelona... ► Artikel lesen | |
| 24.11.25 | Cheelcare Inc: Cheelcare earns Health Canada compliant rating | 2 | Stockwatch | ||
| 16.10.25 | Cheelcare Inc.: Cheelcare Appoints Dave Jones as Director of U.S. Sales | 361 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, is pleased to announce the appointment... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 40,860 | -1,30 % | GOLDMAN SACHS stuft Fresenius SE auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Fresenius von 51 auf 48 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Analyst Richard Felton passte... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 48,130 | +1,35 % | BrightSpring mischt einen Milliardenmarkt auf | Auf den ersten Blick ist das Geschäft von BrightSpring margenschwach und wenig attraktiv. Doch gerade das eröffnet enorme Chancen für Skalierung und Konsolidierung Den vollständigen Artikel lesen ... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 33,790 | -0,47 % | Siemens Healthineers: Aktie im freien Fall - das sind die Gründe | Die Aktie von Siemens Healthineers steht massiv unter Druck und hat ein neues 52-Wochen-Tief erreicht, belastet durch politische Reformen, Zölle und Währungseffekte. Besonders die geplanten Einsparungen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,730 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,810 | -0,68 % | Shortseller-Positionen aktuell: u.a. Cancom, FMC, Hypoport, Renk, TeamViewer, Zalando | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,435 | 0,00 % | S&P Dow Jones Indices: LifeStance Health Group Set to Join S&P SmallCap 600 | NEW YORK, April 27, 2026 /PRNewswire/ -- LifeStance Health Group Inc. (NASD: LFST) will replace Golden Entertainment Inc (NASD: GDEN) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,690 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,695 | -0,58 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| HEARTFLOW | 29,530 | -3,43 % | Heartflow, Inc.: Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026 | ||
| CARL ZEISS MEDITEC | 25,660 | +1,42 % | Was bei Carl Zeiss Meditec gerade passiert: Droht jetzt der nächste große Absturz? - Handeln Sie, bevor es zu spät ist | ||
| ADAPTHEALTH | 13,075 | -2,28 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| PROGYNY | 18,400 | +0,11 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BUTTERFLY NETWORK | 4,920 | 0,00 % | Butterfly Network Inc (BFLY): Top Medical AI Stock to Buy | ||
| GLUCOTRACK | 0,912 | 0,00 % | GlucoTrack, Inc.: Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights | Company prepares to file Investigational Device Exemption (IDE) for Novel CBGM Technology, targeting US Clinical Trial Launch in Second Half of 2026 US Patent and Trademark Office (USPTO) issued patents... ► Artikel lesen | |
| GENEDX | 62,88 | 0,00 % | Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings? |